Indigo Press Release
2022-09-30

Indigo Diabetes Announces First Participant Enrolled in the SHINE Clinical Trial

BELGIUM – Ghent, September 29,…
read more
Astrivax Press Release
2022-09-26

AstriVax, an innovative vaccine platform company, establishes scientific advisory board with world renowned leaders in vaccine development

• Emmanuel Hanon, PhD, will…
read more
Coave Press Release
2022-09-20

Coave Therapeutics to Collaborate with World-Renowned Institute of Neurodegenerative Diseases of Bordeaux to Develop Gene Therapy Programs Targeting Protein Degradation in Neurodegenerative Disorders

Coave Therapeutics to Collaborate with…
read more
Minoryx Press Release
2022-09-20

Minoryx‘s Marketing Authorization Application for its lead candidate leriglitazone validated by EMA for orphan indication X-linked Adrenoleukodystrophy (X-ALD

Minoryx‘s Marketing Authorization Application for…
read more
Immunic Press Release
2022-08-17

Immunic Receives Notice of Allowance for Composition-of-Matter Patent in the United States for IMU-856, a Small Molecule Modulator Targeting Restoration of Intestinal Barrier Function and Regeneration of Bowel Epithelium

Immunic Receives Notice of Allowance for Composition-of-Matter Patent in the United States…
read more
Cardior Press Release
2022-07-27

Cardior Announces First Patient Dosed in Phase 2 Study Evaluating Efficacy and Safety of Non-coding RNABased Lead Candidate CDR132L in Heart Failure Patients PostMyocardial Infarction

Cardior Announces First Patient Dosed…
read more
Immunic Press Release
2022-07-07

Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Maria Törnsén

Immunic, Inc. Strengthens Its Board…
read more
Minoryx Press Release
2022-05-31

Minoryx raises €51 million to support Marketing Authorization Application and launch preparations for X-linked Adrenoleukodystrophy (X-ALD) therapy

Minoryx raises €51 million to…
read more
Immunic Press Release
2022-05-05

Immunic Announces Start of Patient Cohorts in Its Phase 1 Clinical Trial of IMU-856 in Celiac Disease

Immunic Announces Start of Patient…
read more
Press Release Tubulis
2022-05-03

Tubulis Closes €60 Million Series B Financing to Accelerate its ADC Pipeline and Expand its Breadth of Platform Technologies

Tubulis Closes €60 Million Series…
read more